SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP – Elevance Health Inc. Transaction History
SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP portfolio value:
$7.81M
portfolio value
SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP quarter portfolio value change:
-5.87%
quarter
Elevance Health Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.46% | -993 shares | -967K | $454.24 | 17.2K |
Q2 2022 | share | Decrease | -2.54% | -475 shares | -390K | $482.58 | 18.19K |
Q1 2022 | share | Increase | +3.56% | 642 shares | 814K | $491.22 | 18.66K |
Q4 2021 | share | Decrease | -1.43% | -262 shares | 1.53M | $467.15 | 18.02K |
Q3 2021 | share | Decrease | -9.96% | -2.02K shares | -937K | $371.75 | 18.28K |
Q2 2021 | share | Decrease | -13.26% | -3.10K shares | -650K | $379.57 | 20.31K |
Q1 2021 | share | Decrease | -11.65% | -3.08K shares | -105K | $355.81 | 23.41K |
Q4 2020 | share | Decrease | -8.53% | -2.47K shares | 727K | $317.21 | 26.50K |
Q3 2020 | share | Decrease | -4.08% | -1.23K shares | -162K | $264.57 | 28.97K |
Q2 2020 | share | Increase | +0.37% | 111 shares | 1.11M | $258.12 | 30.21K |
Q1 2020 | share | Increase | +0.84% | 252 shares | -2.18M | $222.12 | 30.09K |
Q4 2019 | share | Decrease | -2.55% | -780 shares | 1.66M | $294.45 | 29.84K |
Q3 2019 | share | Increase | +0.13% | 40 shares | -1.27M | $233.43 | 30.62K |
Q2 2019 | share | Decrease | -4.08% | -1.3K shares | -519K | $273.49 | 30.58K |
Q1 2019 | share | Decrease | -7.05% | -2.42K shares | 141K | $277.32 | 31.88K |
Q4 2018 | share | Decrease | -13.75% | -5.47K shares | -1.89M | $253.12 | 34.30K |
Q3 2018 | share | Decrease | -3.87% | -1.6K shares | 1.05M | $263.45 | 39.77K |
Q2 2018 | share | Decrease | -1.97% | -830 shares | 576K | $228.19 | 41.37K |
Q1 2018 | share | Decrease | -1.15% | -490 shares | -334K | $209.94 | 42.20K |
Q4 2017 | share | Increase | +21.48% | 7.55K shares | 2.93M | $214.31 | 42.69K |
Q3 2017 | share | Decrease | -0.71% | -250 shares | 15K | $180.29 | 35.14K |
Q2 2017 | share | Decrease | -0.98% | -350 shares | 747K | $177.98 | 35.39K |
Q1 2017 | share | Decrease | -6.93% | -2.66K shares | 390K | $155.92 | 35.74K |
Q4 2016 | share | Decrease | -7.58% | -3.15K shares | 314K | $135.01 | 38.40K |
Q3 2016 | share | Decrease | -1.45% | -610 shares | -330K | $117.15 | 41.55K |
Q2 2016 | share | Decrease | -0.66% | -280 shares | -362K | $122.16 | 42.16K |
Q1 2016 | share | Increase | +11.27% | 4.3K shares | 581K | $128.65 | 42.44K |